Search - tctmd.com

Displaying 201 - 220 of 2435

Sort: Relevancy | Date

Presentation TCT 2023

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Presenter: Haibo Jia

October 26, 2023

Presentation TCT 2023

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

Presenter: Tobias Koch

October 26, 2023

Presentation TCT 2023

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

Presenter: Masaru Ishida

October 26, 2023

Presentation TCT 2023

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

Presenter: Matthias Bossard

October 26, 2023

Presentation TCT 2023

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

Presenter: Alessandra Laricchia

October 26, 2023

Presentation TCT 2023

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Presenter: Ae-Young Her

October 26, 2023

Presentation TCT 2023

Novel Solutions for High Bleeding Risk Patients

Presenter: Bjorn Redfors

October 26, 2023

Presentation TCT 2023

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

Presenter: Matthew Li Kam Wa

October 26, 2023

Presentation TCT 2023

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

Presenter: Teruyoshi Kume

October 26, 2023

Presentation TCT 2023

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Presenter: Jun-Won Lee

October 26, 2023

Presentation TCT 2023

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

Presenter: Stephan Windecker

October 26, 2023

Presentation TCT 2023

DES to Allow Adaptive Remodeling

Presenter: Daniel Chamie

October 26, 2023

Presentation TCT 2023

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

Presenter: Robert Stoler

October 26, 2023

Presentation TCT 2023

The Future of Combined Technology – DES Plus DCB

Presenter: Carlos Campos

October 26, 2023

Presentation TCT 2023

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

Presenter: Giulio Stefanini

October 26, 2023

Presentation TCT 2023

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

Presenter: Kirstine Hansen

October 25, 2023

Presentation TCT 2023

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

Presenter: Rayyan Hemetsberger

October 25, 2023

Presentation TCT 2023

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

Presenter: Georg Nollert

October 25, 2023

Presentation TCT 2023

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

Presenter: Azfar Zaman

October 25, 2023

Presentation TCT 2023

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Presenter: Jens Trøan

October 25, 2023

Advertisement

Drug-Coated Balloon for Acute Coronary Syndromes: A Multicenter Randomized Non-inferiority Trial (DCB-ACS Trial)

Recurrent Revascularization After Treatment Of Drug-Eluting Stent Restenosis With Drug-Coated Balloon, Plain Balloon Or Drug-Eluting Stent 10-Year Results From the Randomized ISAR-DESIRE 3 Trial

TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation

TCT 660: Treatment of Coronary Lesions With a Novel Crystalline Sirolimus-Coated Balloon

TCT 320: Performance of a Novel Sirolimus-Coated Balloon According to Clinical Presentation: the Eastbourne-Peace Substudy

TCT 277: Comparison of Change in Side-Branch Ostium after Drug-Coated Balloon versus Drug-Eluting Stent versus Medication for the Treatment of De Novo Coronary Bifurcation Lesions

Novel Solutions for High Bleeding Risk Patients

TCT 80: The Everolimus Eluting Synergy MegatronTM Drug-eluting Stent Platform for Aorto-ostial and Proximal Coronary Disease – Early Outcomes from the European Synergy MegatronTM Implanters' Registry

TCT 52: Coronary Bifurcation Bench to Assess the Impact of Stent Strut Link Location in Proximal Balloon Edge Dilation Technique

TCT 250: Transradial versus Transfemoral Access for Bifurcation Percutaneous Coronary Intervention Using Second-generation Drug-eluting Stent

Does Polymer Coating Matter? Biodegradable vs Durable vs Polymer-Free

DES to Allow Adaptive Remodeling

The Modern Era of Ultra-Thin Struts – Is It a True Advantage?

The Future of Combined Technology – DES Plus DCB

Treatment of Patients With Diabetes and Diffuse Disease – Current Limitations

TCT 418: Impact of diabetes on clinical outcomes after percutaneous coronary intervention: 5-year results of the SORTOUT IX trial comparing the polymer-free biolimus A9-coated stent to the ultra-thin strut biodegradable polymer sirolimus-eluting stent

TCT 356: Patients with moderate to severe lesion tortuosity undergoing coronary intervention with newer-generation drug eluting stents – an analysis from the randomized BIOFLOW trials

TCT 185: Safety and Performance Registry for an All-Comers Subject Population with the Limus Eluting Orsiro Mission Stent System Within Daily Clinical Practice: Twelve-Month Results of the BIOFLOW-VIII Registry

TCT 522: Ultrathin Strut Biodegradable Polymer-coated Sirolimus-eluting Stents in an All-comers Patient Population – The Prospective S-FLEX UK-II Registry

TCT 708: Five-Year Outcomes of Patients With Diabetes Mellitus Treated With a Sirolimus-Eluting or a Biolimus-Eluting Stents With Biodegradable Polymer. From the SORT OUT VII Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content